Slide 1: Q2 2015 Financial Results Conference Call
Q2 2015 Financial Results Conference Call August 11, 2015
Slide 2: Safe Harbor Summary
Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections,
Slide 3: Agenda
Agenda Fried Vancraen • Q2 2015 Highlights Founder & CEO • Q2 2015 Financial Results Peter Leys Executive Chairman • Q2 2015 Operational Achievements and Q3 2015 Operational Priorities Frederic Merckx CFO • Q&A 3
Slide 4: Q2 2015 Highlights
Q2 2015 Highlights Total revenue increased 29% to 24,772 kEUR from prior year; organic growth was 23% as compared to Q2 2014. 3D Printing Software sales increased 45% from prior year. Total (3D Printing and Medical) software sales were 37% of total revenue in Q2 2015, as compared to 31% in Q2
Slide 5: Consolidated Results
Consolidated Results Q2 2015 Revenue Consolidated Revenue Consolidated Adjusted EBITDA Margin (€ in thousands) 3D Printing Software Industrial 25% Production €24,772 42% 7.1% (0.7)% €19,238 Medical €1,372 33% (€179) Q2 2015 Revenue Q2 2014 Q2 2015 Q2 2014 Q2 2015 End Parts Software 70% of Q2 2015
Slide 6: 3D Printing Software Segment
3D Printing Software Segment Revenue EBITDA Margin (€ in thousands) 40.4% 33.2% €6,078 €2,015 €4,198 €1,696 Q2 2014 Q2 2015 Q2 2014 Q2 2015 Revenue from new licenses for Q2 2015 increased by 51% from the prior year. Q2 2015 revenue generated from OEMs increased by 124% from the prior year (1).
Slide 7: Medical Segment
Medical Segment Revenue EBITDA Margin (€ in thousands) 11.1% (4.1)% €793 €8,315 (€342) €7,163 Q2 2014 Q2 2015 Q2 2014 Q2 2015 Q2 2015 medical software revenue increased 84% from the prior year (18% excluding OrthoView) and represented 39% of total medical sales (as compared to 25% in Q2 2014). S
Slide 8: Industrial Production Segment
Industrial Production Segment Revenue EBITDA Margin (€ in thousands) 6.3% (1.4)% €10,379 €7,986 €500 (€147) Q2 2014 Q2 2014 Q2 2015 Q2 2015 40% growth in sales of end parts for Q2 2015 over the prior year, with end parts representing 29% of total segment sales, as compared to 27% in Q2 2014. Num
Slide 9: Income Statement Highlights
Income Statement Highlights (in thousands of euros, except where indicated) Q2 2015 2014 Revenue 24,772 19,238 Cost of sales (10,445) (7,535) Gross profit 14,327 11,703 Research & Development Expenses (4,371) (3,563) Sales & Marketing Expenses (9,620) (6,156) General & Administrative Expenses (3,747
Slide 10: Other Financial Highlights
Other Financial Highlights (in thousands of euros) 06/30/2015 12/31/2014 Cash & equivalents* 52,699 61,019 Receivables 19,917 18,370 Inventories 4,595 3,660 Payables 10,425 7,333 Total borrowings 16,741 17,347 Total equity 82,360 85,167 Total liabilities and equity 135,549 133,221 (in thousands of e
Slide 11: Operational Review
Operational Review Q2 Operational Accomplishments Q3 Operational Priorities SOFTWARE Launched additional build processors Further roll out build processor program Joined 3mf consortium • Xi-An Bright Laser build processor launched in July Initiate commercial roll out of AMCP platform Launc
Slide 12: Q&A
Visionary company and leadership that has driven advancement of the 3D printing industry Commitment to expanding 3D printing technology through constant ongoing Research & Q&A Development At the forefront of 3D printing growth with a compelling and unique business and financial model 12
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation For the three months ended June 30 (in thousands of euros) 2015 2014 Net profit/(loss) (3,013) (223) Income taxes 75 98 Financial expense 1,286 210 Financial income (348) (34) Share in Loss in a Joint Venture 63 0 Depreciation & amortization 1,506 1,014 EBITDA (431) 1,